v3.26.1
CONDENSED BALANCE SHEETS - USD ($)
Mar. 31, 2026
Dec. 31, 2025
Current assets:    
Cash $ 431,326 $ 619,576
Prepaid expenses 350,421  
Total current assets 781,747 975,309
Cash and investments held in Trust Account 370,939,623 367,742,183
Total assets 371,721,370 368,717,492
Current liabilities:    
Accrued expenses, formation and offering costs 2,682,441 2,686,141
Total current liabilities 2,682,441 2,686,141
Liabilities, Noncurrent [Abstract]    
Advisory fee 10,764,000 10,764,000
Deferred underwriting compensation 10,764,000 10,764,000
Total liabilities 29,233,641 32,376,841
Commitments and contingencies
Class A ordinary shares subject to possible redemption, 35,880,000 shares (at redemption value of $10.33 and $10.25 per share at March 31, 2026 and December 31, 2025, respectively) 370,712,123 367,642,183
Shareholders' deficit:    
Preferred shares, $0.0001 par value; 1,000,000 shares authorized, none issued or outstanding at March 31, 2026 and December 31, 2025
Additional paid-in capital   0
Accumulated deficit (28,225,314) (31,302,452)
Total shareholders' deficit (28,224,394) (31,301,532)
Total liabilities and shareholders' deficit 371,721,370 368,717,492
Class A Ordinary Shares    
Shareholders' deficit:    
Common stock value 23 23
Class B Ordinary Shares    
Shareholders' deficit:    
Common stock value [1],[2] 897 897
Public Warrants    
Liabilities, Noncurrent [Abstract]    
Public warrants derivative liability $ 5,023,200 $ 8,162,700
[1] On June 30, 2023, the Sponsor paid $25,000 to cover certain of the Company’s offering costs in consideration of 11,500,000 Founder Shares. On February 3, 2025, the Sponsor surrendered for no consideration 4,025,000 Founder Shares. On May 1, 2025, the Company effected a stock dividend with respect to its Class B ordinary shares of 1,495,000 shares thereof, resulting in an aggregate of 8,970,000 outstanding shares of Class B ordinary shares. All share data has been retroactively presented.
[2] On May 5, 2025, the Company consummated its Initial Public Offering and sold 35.88 million Units, which includes the full exercise of the underwriter's over-allotment option, hence the 1,170,000 Class B ordinary shares are no longer subject to forfeiture.